AVALO THERAPEUTICS INC

AVALO Therapeutics Shares Drop 6.98% After 55.92% Decline – Market Cap $371.7 M

AVALO Therapeutics stock drops 6.98% as market cap falls to $371.7M, amid 55.92% decline since October; see related biotech losses.

AVALO THERAPEUTICS INC
United States
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Elliot Mercer

26/10/2026, 13:29

2 minutes to read

Avalo Therapeutics (AVTX) Shares Drop 39% – Market Update 23 Oct 2026

Explore Avalo Therapeutics’ latest stock dip: price down 39% yet the firm’s precision‑medicine pipeline for immunology and rare diseases stays strong.

AVALO THERAPEUTICS INC
United States
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Elliot Mercer

23/10/2026, 13:58

2 minutes to read

AVALO Therapeutics Shares Jump 6.6% as Investors Gain Confidence in Precision Medicine Pipeline

Investors lift Avalo Therapeutics stock 6.6% as it rebounds from a 23.5% monthly dip, amid optimism over its precision‑medicine pipeline and peer gains.

AVALO THERAPEUTICS INC
United States
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Jake Connors

21/10/2026, 21:18

3 minutes to read

AVALO THERAPEUTICS INC

AVALO Therapeutics Shares Drop 6.98% After 55.92% Decline – Market Cap $371.7 M

Avalo Therapeutics (AVTX) Shares Drop 39% – Market Update 23 Oct 2026

AVALO Therapeutics Shares Jump 6.6% as Investors Gain Confidence in Precision Medicine Pipeline

AVALO Therapeutics Shares Drop 6.98% After 55.92% Decline – Market Cap $371.7 M

Avalo Therapeutics (AVTX) Shares Drop 39% – Market Update 23 Oct 2026